Literature DB >> 28825336

Glycocalyx degradation leads to blood-brain barrier dysfunction and brain edema after asphyxia cardiac arrest in rats.

Jiajia Zhu1, Xing Li1, Jia Yin1, Yafang Hu1, Yong Gu1, Suyue Pan1.   

Abstract

The role of glycocalyx in blood-brain barrier (BBB) integrity and brain damage is poorly understood. Our study aimed to investigate the impacts of endothelial glycocalyx on BBB function in a rat model of cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). Male Sprague-Dawley rats subjected to 8-min asphyxia CA/CPR. Compared to controls, glycocalyx was mildly injured by CA, severely disrupted by hyaluronidase (HAase) with CA, and mitigated by hydrocortisone (HC) with CA. More importantly, the disruption of glycocalyx caused by HAase treatment was associated with higher BBB permeability and aggravated brain edema at 24 h after return of spontaneous circulation, as well as lower survival rate and poorer neurologic outcome at seventh day. Reversely, less degradation of glycocalyx by HC treatment was accompanied by higher seven-day survival rate and better neurologic outcome. Mechanistically, HAase treatment further increased CA/CPR-induced activation of glia cells and expression of inflammatory factors, whereas HC decreased them in the brain cortex and hippocampus. Glycocalyx degradation results in BBB leakage, brain edema, and deteriorates neurologic outcome after asphyxia CA/CPR in rats. Preservation of glycocalyx by HC could improve neurologic outcome and reduce BBB permeability, apparently through reduced gene transcription-protein synthesis and inflammation.

Entities:  

Keywords:  Brain edema; blood–brain barrier; cardiac arrest; endothelium; steroid

Mesh:

Year:  2017        PMID: 28825336      PMCID: PMC6259325          DOI: 10.1177/0271678X17726062

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  37 in total

Review 1.  Glycocalyx and endothelial (dys) function: from mice to men.

Authors:  Bernard M van den Berg; Max Nieuwdorp; Erik S G Stroes; Hans Vink
Journal:  Pharmacol Rep       Date:  2006       Impact factor: 3.024

Review 2.  The endothelial glycocalyx: composition, functions, and visualization.

Authors:  Sietze Reitsma; Dick W Slaaf; Hans Vink; Marc A M J van Zandvoort; Mirjam G A oude Egbrink
Journal:  Pflugers Arch       Date:  2007-01-26       Impact factor: 3.657

3.  Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council.

Authors:  Robert W Neumar; Jerry P Nolan; Christophe Adrie; Mayuki Aibiki; Robert A Berg; Bernd W Böttiger; Clifton Callaway; Robert S B Clark; Romergryko G Geocadin; Edward C Jauch; Karl B Kern; Ivan Laurent; W T Longstreth; Raina M Merchant; Peter Morley; Laurie J Morrison; Vinay Nadkarni; Mary Ann Peberdy; Emanuel P Rivers; Antonio Rodriguez-Nunez; Frank W Sellke; Christian Spaulding; Kjetil Sunde; Terry Vanden Hoek
Journal:  Circulation       Date:  2008-10-23       Impact factor: 29.690

4.  Physiological levels of A-, B- and C-type natriuretic peptide shed the endothelial glycocalyx and enhance vascular permeability.

Authors:  Matthias Jacob; Thomas Saller; Daniel Chappell; Markus Rehm; Ulrich Welsch; Bernhard F Becker
Journal:  Basic Res Cardiol       Date:  2013-04-06       Impact factor: 17.165

5.  Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model.

Authors:  S Yini; Z Heng; A Xin; M Xiaochun
Journal:  Acta Anaesthesiol Scand       Date:  2014-10-14       Impact factor: 2.105

6.  VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.

Authors:  Samuel Valable; Joan Montaner; Anita Bellail; Vincent Berezowski; Julien Brillault; Romeo Cecchelli; Didier Divoux; Eric T Mackenzie; Myriam Bernaudin; Simon Roussel; Edwige Petit
Journal:  J Cereb Blood Flow Metab       Date:  2005-11       Impact factor: 6.200

7.  Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion.

Authors:  Daniel Chappell; Nina Dörfler; Matthias Jacob; Markus Rehm; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Shock       Date:  2010-08       Impact factor: 3.454

8.  Severe blood-brain barrier disruption and surrounding tissue injury.

Authors:  Bo Chen; Beth Friedman; Qun Cheng; Phil Tsai; Erica Schim; David Kleinfeld; Patrick D Lyden
Journal:  Stroke       Date:  2009-11-05       Impact factor: 7.914

9.  Inflammation- and ischemia-induced shedding of venular glycocalyx.

Authors:  A W Mulivor; H H Lipowsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-02       Impact factor: 4.733

10.  Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion.

Authors:  Daniel Chappell; Matthias Jacob; Klaus Hofmann-Kiefer; Markus Rehm; Ulrich Welsch; Peter Conzen; Bernhard F Becker
Journal:  Cardiovasc Res       Date:  2009-03-22       Impact factor: 10.787

View more
  30 in total

1.  Effect of diabetes and hyaluronidase on the retinal endothelial glycocalyx in mice.

Authors:  Wendy Leskova; Haley Pickett; Randa S Eshaq; Bandana Shrestha; Christopher B Pattillo; Norman R Harris
Journal:  Exp Eye Res       Date:  2018-11-13       Impact factor: 3.467

2.  Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  J Cereb Blood Flow Metab       Date:  2020-09-14       Impact factor: 6.200

Review 3.  The post-cardiac arrest syndrome: A case for lung-brain coupling and opportunities for neuroprotection.

Authors:  Nguyen Mai; Kathleen Miller-Rhodes; Sara Knowlden; Marc W Halterman
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

4.  Ischemic Preconditioning Alleviates Cerebral Ischemia-Reperfusion Injury by Interfering With Glycocalyx.

Authors:  Yi-Na Zhang; Qiong Wu; Nan-Nan Zhang; Hui-Sheng Chen
Journal:  Transl Stroke Res       Date:  2022-09-28       Impact factor: 6.800

Review 5.  Proteoglycans and glycosaminoglycans in central nervous system injury.

Authors:  Noah Siddiqui; Kaori Oshima; Joseph A Hippensteel
Journal:  Am J Physiol Cell Physiol       Date:  2022-05-25       Impact factor: 5.282

6.  Endothelial Protrusions in Junctional Integrity and Barrier Function.

Authors:  Natascha G Alves; Zeinab Y Motawe; Sarah Y Yuan; Jerome W Breslin
Journal:  Curr Top Membr       Date:  2018-09-27       Impact factor: 3.049

Review 7.  Surface charge, glycocalyx, and blood-brain barrier function.

Authors:  Fruzsina R Walter; Ana R Santa-Maria; Mária Mészáros; Szilvia Veszelka; András Dér; Mária A Deli
Journal:  Tissue Barriers       Date:  2021-05-18

Review 8.  The neurovascular extracellular matrix in health and disease.

Authors:  Aric F Logsdon; Elizabeth M Rhea; May Reed; William A Banks; Michelle A Erickson
Journal:  Exp Biol Med (Maywood)       Date:  2020-12-10

9.  Changes in endothelial glycocalyx layer protective ability after inflammatory stimulus.

Authors:  Luis F Delgadillo; Elena B Lomakina; Julia Kuebel; Richard E Waugh
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-16       Impact factor: 4.249

10.  Lactadherin promotes microvesicle clearance to prevent coagulopathy and improves survival of severe TBI mice.

Authors:  Yuan Zhou; Wei Cai; Zilong Zhao; Tristan Hilton; Min Wang; Jason Yeon; Wei Liu; Fangyi Zhang; Fu-Dong Shi; Xiaoping Wu; Perumal Thiagarajan; Min Li; Jianning Zhang; Jing-Fei Dong
Journal:  Blood       Date:  2017-11-21       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.